I think it's the sheer lack of scientific information. None of the deals mean anything if they are largely tied to FDA approval and we have no confirmation that there is a positive result for the peptides/blood work.

If we go thru this call on Thursday without finding out where the science is, the SP is going to struggle, IMO.